Spots Global Cancer Trial Database for Detection of Tumor DNA in Blood Samples From Cancer Patients
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Detection of Tumor DNA in Blood Samples From Cancer Patients
Official Title: Detection of Tumor DNA in Blood Samples From Patients With Late Stage Cancer and "Healthy Controls"
Study ID: NCT02288754
Interventions
Study Description
Brief Summary: The aim of this study is to employ genomic detection methodologies to measure the relative amount of tumor nucleic acids in the blood of a cancer patient with diagnosed metastatic disease that is either commencing, currently undergoing or completed cytotoxic chemotherapy treatment. More generally, this approach will allow us to develop a quantitative measure of therapy efficacy via the counting of the relative changes in tumor molecules over the course of treatment.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: Yes
Locations
Cancer Care Associates, Torrance, California, United States
Contact Details
Name: Haluk Tezcan, MD
Affiliation: Lexent Bio
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
